Aqua Bio Technology ASA (OSL:ABTEC)
Norway
· Delayed Price · Currency is NOK 0.4955
-0.0135 (-2.65%)
At close: Dec 5, 2025
Aqua Bio Technology ASA Income Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 94.88 | 106.56 | 18.41 | 7.02 | 1.56 | 0.44 | Upgrade
|
| Other Revenue | 6.63 | 0.62 | 0.33 | 0.14 | 0.42 | 0.37 | Upgrade
|
| Revenue | 101.51 | 107.17 | 18.74 | 7.16 | 1.98 | 0.81 | Upgrade
|
| Revenue Growth (YoY) | 12.93% | 472.00% | 161.63% | 262.49% | 143.11% | -37.26% | Upgrade
|
| Cost of Revenue | 101.02 | 104.54 | 8.34 | 4.69 | 0.95 | 0.98 | Upgrade
|
| Gross Profit | 0.49 | 2.63 | 10.4 | 2.47 | 1.02 | -0.17 | Upgrade
|
| Selling, General & Admin | 99.09 | 113.77 | 36 | 21.52 | 17.79 | 15.82 | Upgrade
|
| Operating Expenses | 109.13 | 125.51 | 39.68 | 23.18 | 18.88 | 15.94 | Upgrade
|
| Operating Income | -108.64 | -122.88 | -29.28 | -20.71 | -17.86 | -16.1 | Upgrade
|
| Interest Expense | -23.62 | -19.01 | -4.49 | -2.24 | -1.46 | -0 | Upgrade
|
| Interest & Investment Income | 0.3 | 0.3 | 0.06 | 0 | - | 0 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.01 | -0.01 | -0.31 | -0.15 | 0.2 | -0.06 | Upgrade
|
| Other Non Operating Income (Expenses) | 2.16 | -0.73 | -0.31 | - | - | 1.21 | Upgrade
|
| EBT Excluding Unusual Items | -129.81 | -142.33 | -34.34 | -23.1 | -19.11 | -14.95 | Upgrade
|
| Gain (Loss) on Sale of Assets | -44.71 | -44.71 | - | - | - | - | Upgrade
|
| Asset Writedown | -105.34 | -163.7 | -0.8 | - | - | - | Upgrade
|
| Other Unusual Items | 5.57 | 5.57 | 14.3 | 4.34 | - | - | Upgrade
|
| Pretax Income | -274.28 | -345.17 | -20.85 | -18.75 | -19.11 | -14.95 | Upgrade
|
| Income Tax Expense | -8.24 | -7.81 | 0.18 | -0.02 | - | -0.25 | Upgrade
|
| Net Income | -144.7 | -337.35 | -21.02 | -18.74 | -19.11 | -14.7 | Upgrade
|
| Net Income to Common | -144.7 | -337.35 | -21.02 | -18.74 | -19.11 | -14.7 | Upgrade
|
| Shares Outstanding (Basic) | - | 68 | 31 | 21 | 19 | 16 | Upgrade
|
| Shares Outstanding (Diluted) | - | 68 | 31 | 21 | 19 | 16 | Upgrade
|
| Shares Change (YoY) | - | 122.82% | 47.34% | 7.88% | 18.67% | 25.77% | Upgrade
|
| EPS (Basic) | - | -4.96 | -0.69 | -0.91 | -0.99 | -0.91 | Upgrade
|
| EPS (Diluted) | - | -4.96 | -0.69 | -0.92 | -0.99 | -0.91 | Upgrade
|
| Free Cash Flow | -17.62 | -47.93 | -19.34 | -15.45 | -20.97 | -13.47 | Upgrade
|
| Free Cash Flow Per Share | - | -0.70 | -0.63 | -0.74 | -1.09 | -0.83 | Upgrade
|
| Gross Margin | 0.48% | 2.45% | 55.51% | 34.52% | 51.82% | -20.78% | Upgrade
|
| Operating Margin | -107.02% | -114.66% | -156.29% | -289.21% | -903.89% | -1981.81% | Upgrade
|
| Profit Margin | -142.55% | -314.77% | -112.21% | -261.62% | -967.45% | -1809.43% | Upgrade
|
| Free Cash Flow Margin | -17.35% | -44.72% | -103.24% | -215.73% | -1061.42% | -1657.67% | Upgrade
|
| EBITDA | -164.26 | -116.33 | -27.27 | -19.47 | -16.9 | -15.99 | Upgrade
|
| EBITDA Margin | -161.82% | -108.55% | -145.57% | -271.94% | - | - | Upgrade
|
| D&A For EBITDA | -55.62 | 6.54 | 2.01 | 1.24 | 0.96 | 0.11 | Upgrade
|
| EBIT | -108.64 | -122.88 | -29.28 | -20.71 | -17.86 | -16.1 | Upgrade
|
| EBIT Margin | -107.02% | -114.65% | -156.29% | -289.21% | - | - | Upgrade
|
| Revenue as Reported | 101.51 | 107.17 | 18.74 | 7.16 | 1.98 | 0.81 | Upgrade
|
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.